Genetic (monogenic) heart disease precision medicine study
Part of Heart & circulation clinical trials.
This study looks at people with a specific type of inherited (genetic) heart condition. It tests a “precision medicine” approach, meaning care guided by your genetic cause, and requires regular follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with an inherited heart condition caused by one gene (monogenic) using standard guidelines
- Your diagnosis should match what the study considers “monogenic cardiovascular”
- You are willing to read and sign the informed consent form
- You agree to attend follow-up visits during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies children with inherited (genetic) heart conditions that started before age 16. It may help improve how doctors identify the genetic cause and understand which families are affected.
This study looks for new body markers (including possible genetic traits) to better predict who is likely to have future cardiovascular events. Your results could help doctors estimate risk and choose prevention strategies more accurately.
This trial uses a polygenic risk score to see if knowing your genetic risk for coronary artery disease can help prevent a first heart attack. If you have an intermediate 10-year risk and no prior heart events, you may be eligible.
This trial looks at how learning about your genetic risk for heart disease might help prevent it. You will get a personalized report and guidance.
This study is looking for people with inherited heart muscle disease that may be genetic. It uses advanced genetic testing to better understand the cause.
This study looks at the genes behind cardiomyopathy (a disease of the heart muscle). It may help explain why it happens in your family and guide better care for you and relatives.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.